Access cutting-edge brain cancer treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.
Access brain cancer specialists in Dallas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain cancer treatment provided free
This multi-site, Phase 1/2a clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (perillyl alcohol) for the treatment of patients with radiographically-confirmed progression of Grade IV glioma or recurrent primary or secondary Grade IV glioma. The study will have two phases, Phase 1 and Phase 2a. Phase 1 is a standard cohort dose escalation 3+3 design used to determine the maximum tolerated dose for Phase 2a. There will
Sponsor: Neonc Technologies, Inc.
Check if you qualify for this brain cancer clinical trial in Dallas, TX
If you're searching for brain cancer treatment options in Dallas, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.